Salarius Pharmaceuticals, Inc. , a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments.
Salarius Pharmaceuticals stock last closed at $0.81, down 6.68% from the previous day, and has decreased 96.58% in one year. It has underperformed other stocks in the Biotechnology industry by 0.5 percentage points. Salarius Pharmaceuticals stock is currently +13.92% from its 52-week low of $0.71, and -99.25% from its 52-week high of $108.00.
As of Dec 11, 2025, there are 5.86M shares of SLRX outstanding. The market value of SLRX is $4.75M. In the past 24 hours, 402,000 SLRX shares were traded.
How to Buy Salarius Pharmaceuticals Stock
Not sure how to invest in Salarius Pharmaceuticals stock? Here's how.
Decide where to buy Salarius Pharmaceuticals stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you decide where to buy Salarius Pharmaceuticals stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Choose your payment method and add your details.
Evaluate Salarius Pharmaceuticals stock: The Salarius Pharmaceuticals ticker symbol is SLRX. Is Salarius Pharmaceuticals stock a good investment? Should you buy shares of SLRX? How do SLRX's underlying business fundamentals look? Do top analysts think Salarius Pharmaceuticals is a good buy? Why has SLRX's stock price moved recently? (Hint: Our stock market analysis website can help you understand if SLRX is a good stock to buy).
Execute your SLRX purchase: Decide if you will purchase SLRX shares at the current market price or use a limit order to buy SLRX shares at a specific price.
Get notifications regarding your investment in SLRX: Create a watchlist to important updates regarding your new investment in Salarius Pharmaceuticals stock.
Step 1: Decide where to buy Salarius Pharmaceuticals stock
You will need a brokerage account in order to access the NASDAQ market and buy SLRX stock.
A brokerage account is an investment account that enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world financial markets: From Tech to Real Estate, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've picked the right brokerage, it's time to fill out some personal information so you are able to invest in SLRX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Salarius Pharmaceuticals stock
After you have figured out the best place to buy Salarius Pharmaceuticals stock, it's crucial to evaluate their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
Salarius Pharmaceuticals Metrics
SLRX Price
$0.81
1w %
-7%
1y %
-96.58%
5y %
-99.97%
P/E
-0.02x
P/B
1.12x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$5.00M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$4.75M
Next Earnings
N/A
Next Dividend
N/A
SLRX Overview
WallStreetZen was built to help part-time investors do more accurate fundamental analysis quickly.
Last year, SLRX revenue was $0.00. Over the past five year, SLRX's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 43.95%.
No, Salarius Pharmaceuticals doesn't provide an income stream by paying out dividends.
What do other traders have to say about SLRX?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your SLRX purchase
There are two main options:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are generally the easiest way to buy.
Limit order: A limit order lets you buy or sell a stock at a specific price (or better). If you want to be sure you're buying or selling at an exact price limit, place a limit order.
Click the Open Trade button and your broker will execute your order.
If you want more assistance buying stocks on eToro, watch the how to video below:
How much does it cost to buy one Salarius Pharmaceuticals share?
As of Dec 11, 2025, it costs $0.81 to buy one share of Salarius Pharmaceuticals stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.41, you can buy 0.5 shares of SLRX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.